Diclofenac reduces the risk of Alzheimer’s disease: a pilot analysis of NSAIDs in two US veteran populationsOlaf Stüve, Bertis B. Little, Rick Weideman et al.|Therapeutic Advances in Neurological Disorders|2020Cited by 42
Microglia as a cellular target of diclofenac therapy in Alzheimer’s diseaseBarbara E. Stopschinski, Olaf Stüve, Rick Weideman et al.|Therapeutic Advances in Neurological Disorders|2023Cited by 26
Estimating the Risk of Cardiovascular Events in U.S. Veterans Using the SMART Risk ScoreSubhash Banerjee, Bertis B. Little, Rick Weideman et al.|JACC Advances|2024Cited by 3
ESTIMATING CARDIOVASCULAR EVENT RATES IN U.S. VETERANS USING THE SMART RISK SCORESubhash Banerjee, Emmanouil S. Brilakis, David Jacob et al.|Journal of the American College of Cardiology|2021Cited by 0
Abstract 13028: Estimating Cardiovascular Event Rates in US Veterans Using the SMART Risk ScoreMilan Ravishankar, Subhash Banerjee, Patrick T. Strickland et al.|Circulation|2023Cited by 0